Trialbee has announced a strategic partnership with Savvy Cooperative. This partnership primarily addresses two pain points for patients—the challenge of finding appropriate clinical trials and the lack of opportunity to express their experiences to the industry as consumers of healthcare—an area still ripe for disruption.
As a practical example, Savvy Cooperative members will be introduced to specific clinical trials with an invitation to participate in pre-screening and referral to sites via the Trialbee Honey platform. At the end of the process, all potential participants who come through Honey, regardless of channel, will be invited to join the #AskPatients™ community to share their experiences for future research. While the collaboration is inclusive of all members in the Savvy community, lupus and multiple sclerosis have been selected as pilot indications to demonstrate the power of the partnership as these patients are simultaneously active yet traditionally under recruited.
Trialbee Partners with Savvy Cooperative to Bring the Voice of the Patient into Clinical Trials Earlier. (2023, March 29). Cision PRWeb.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.